Clinical Trial Update: HILT for Meralgia Paresthetica [NA]

View source ↗

Summary

The clinical trial HILT for Meralgia Paresthetica sponsored by Ahram Canadian University has completed (NCT05893732) evaluating Meralgia paresthetica and latera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lateral Femoral Cutaneous Nerve Entrapment
• Meralgia Paresthetica

Drugs mentioned

• High-Intensity Laser Therapy (HILT)

Snippet

Sponsor: Ahram Canadian University | Conditions: Meralgia Paresthetica, Lateral Femoral Cutaneous Nerve Entrapment | NA | Status: COMPLETED